Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.

Abboud, P; Lemée, V; Gargala, G; Brasseur, P; Ballet, J J; Borsa-Lebas, F; Caron, F; Favennec, L · Clin Infect Dis · 2001

case_report · Level V

Where this comes from

Abstract

A case of metronidazole- and albendazole-resistant giardiasis in a patient with the acquired immunodeficiency syndrome was successfully treated with nitazoxanide (1.5 g twice a day for 30 days). Animal studies and in vitro assays showed that the isolate was resistant to both metronidazole and albendazole and susceptible to nitazoxanide.

Medical subject headings